TGFB1 and atrial fibrillation: Although miRNA-21 was not associated with any AF subtypes (paroxysmal or persistent), there is evidence that miRNA-21 and its target protein are linked to the atrial fibrosis process, acting on profibrotic regulatory mechanisms such as in the transforming growth factor-beta (TGF-β)-induced pathway.